| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioaffinity Technologies, Inc. (BIAF) has 0 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. BIAF is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | Edwards James Michael | Chief Financial Officer | Buy | 2,448 | $0.00 | - | +8.8% | |
| Aug 31, 2022 | Rubin Gary D | Director, 10% Owner | Buy | 16,326 | $0.00 | - | +1.0% | |
| Aug 31, 2022 | Girgenti Steven | Executive Chairman | Buy | 40,916 | $0.00 | - | +5.0% | |
| Aug 31, 2022 | Zannes Maria | President, CEO | Buy | 16,326 | $0.00 | - | +457.2% | |
| Aug 31, 2022 | Diamond Stuart | Director | Buy | 4,081 | $0.00 | - | New | |
| Aug 31, 2022 | Anderson Robert A. | Director | Buy | 4,081 | $0.00 | - | New | |
| Aug 31, 2022 | Knight Peter S | Director | Buy | 8,163 | $0.00 | - | +57.1% |